Helix TCS Deploys North Dakota's Government Cannabis Traceability Program On-Time

DENVER, March 6, 2019 /PRNewswire/ -- Helix TCS, Inc. (HLIX) (the "Company"), through its cannabis seed to sale tracking and point of sale subsidiary, BioTrackTHC, has officially deployed North Dakota's government medical cannabis traceability system that will track and trace the state's entire medical cannabis supply chain for compliance and regulatory oversight. As legal cannabis programs continue to receive national media attention due to rollout delays and functionality issues, the Company is proud to highlight its perfect track record in meeting go-live deadlines for its 9 government contracted traceability solutions.

"We are very pleased with the BioTrackTHC solution and thank the team for their commitment in launching our state's system in a timely fashion," stated Jason Wahl, Director of the Division of Medical Marijuana. "We appreciated the BioTrackTHC team's cooperation and assistance provided throughout the implementation of the system."

As the leading provider of seed to sale tracking and point of sale software to the legal cannabis industry, BioTrackTHC currently holds 9 government cannabis traceability contracts across 7 states, the city of Arcata, CA., and Puerto Rico. Cannabis traceability systems play a vital role in helping legal cannabis programs to reach a fully operational status because without them, businesses and consumers are unable to guarantee product safety and quality, ultimately creating issues for the community and patients.

"As legal cannabis programs take shape, implementing sound and proven cannabis tracking technology, on time and on budget, with the required functionality and security, is essential to ensuring patient safety and allowing the industry to operate effectively," said Zachary L. Venegas, Executive Chairman and CEO of Helix TCS, Inc. "We are proud to play this vital role for North Dakota's medical cannabis program and look forward to assisting both businesses and governments to accomplish this in markets within the U.S. and abroad."

About Helix TCS, Inc.
BioTrackTHC is a wholly-owned subsidiary of Helix TCS, Inc. Helix TCS, Inc. (HLIX) is a leading provider of ancillary services for the legal cannabis industry, helping owners and operators of licensed cannabis businesses stay competitive and compliant while mitigating risk. Through its proprietary technology suite and security services, Helix TCS provides comprehensive supply chain management, compliance tools, and asset protection for any license type in any regulated cannabis market. Helix TCS's products reach over 2,000 customer locations in 33 states and 6 countries and has processed over $18 billion in cannabis sales. For more information on BioTrackTHC, visit www.biotrack.com. For more information on Helix TCS and to sign up for investor updates, visit us at www.helixtcs.com.

Forward-Looking Statements
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements.  Actual results might differ materially from those explicit or implicit in the forward-looking statements.  Important factors that could cause actual results to differ materially include: our ability to fund our operations and pay any outstanding debt; fluctuations in our financial results; general economic risks; the volatile nature of the market for our products and services and other factors that could impact our anticipated growth; our ability to manage our growth; changes in laws and regulations regarding the cannabis industry and service providers in the cannabis industry; reliance on key personnel; our ability to compete effectively; security and other risks associated with our business; intellectual property risks; and other risk factors set forth from time to time in our SEC filings.  Helix TCS assumes no obligation and does not intend to update these forward-looking statements, except as required by law.